Patients undergoing elective coronary artery bypass graft surgery (CABG) are treated with platelet inhibitors to reduce myocardial infarction and mortality.However, this can increase perioperative bleeding. A retrospective analysis of the data in our institution has revealed a significant increase in transfusion requirements after elective CABG since 5 years. The aim of our study is to observe if this increase in transfusion requirements is due to platelet inhibitors or due to other coagulation abnormalities resulting from other anticoagulants.
Study Type
OBSERVATIONAL
Enrollment
100
if specific coagulation abnormalities are observed which increase patient's risk of bleeding, appropriate treatment will start
Cliniques Universitaires Saint Luc
Brussels, Brussels Capital, Belgium
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.